Rexus, a bit of an unfair call imo, some of us were smart enough to sell out yesterday and buy back cheaper today, nothing to do with balls mate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025